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Statistical modeling for selecting housekeeper genes <p>Genes that exhibit minimal variation in messenger RNA (mRNA) quantity across a variety of cell types and biological conditions pro- vide valuable controls for relative quantification. Normalizing quantitative data with housekeeper genes has many applications, from iden- tifying genes regulated during embryogenesis to developing new cancer diagnostics. Although finding biological significance in gene- expression data can rely heavily on the performance of the housekeeper genes, there is a paucity of information on testing these genes for  their suitability for this role.</p>
Abstract
There is a need for statistical methods to identify genes that have minimal variation in expression
across a variety of experimental conditions. These 'housekeeper' genes are widely employed as
controls for quantification of test genes using gel analysis and real-time RT-PCR. Using real-time
quantitative RT-PCR, we analyzed 80 primary breast tumors for variation in expression of six
putative housekeeper genes (MRPL19 (mitochondrial ribosomal protein L19), PSMC4 (proteasome
(prosome, macropain) 26S subunit, ATPase, 4), SF3A1 (splicing factor 3a, subunit 1, 120 kDa), PUM1
(pumilio homolog 1 (Drosophila)),  ACTB  (actin, beta) and GAPD  (glyceraldehyde-3-phosphate
dehydrogenase)). We present appropriate models for selecting the best housekeepers to
normalize quantitative data within a given tissue type (for example, breast cancer) and across
different types of tissue samples.
Background
Genes that exhibit minimal variation in messenger RNA
(mRNA) quantity across a variety of cell types and biological
conditions provide valuable controls for relative quantifica-
tion. Normalizing quantitative data with housekeeper genes
has many applications, from identifying genes regulated dur-
ing embryogenesis to developing new cancer diagnostics.
Although finding biological significance in gene-expression
data can rely heavily on the performance of the housekeeper
genes, there is a paucity of information on testing these genes
for their suitability for this role.
The copy number of a housekeeper gene should be propor-
tional to the amount of poly(A) RNA present in the sample
and this proportion should be maintained across a variety of
experimental conditions. As nucleic acids show high absorb-
ance at 260 nm (A260), spectrophotometers provide approxi-
mate amounts of total DNA/RNA present in a sample. Using
absorbance methods alone, however, gives no information
about the type of nucleic acid (for example DNA versus RNA)
or contributions from different nucleic acid fractions (for
example rRNA versus mRNA). It is assumed that mRNA com-
prises approximately 1-3% of the total RNA. However, this
contribution may change depending on the extraction
method used. For instance, column extraction methods pro-
vide better exclusion of ribosomal RNA than solvent extrac-
tion methods [1]. By combining capillary electrophoresis with
absorbance, it is possible to accurately quantify these differ-
ent fractions [2].
Traditionally, housekeepers have been used in Northern blot
analysis to represent the amount of mRNA in the sample and
to control for sample loading, blot transfer and probe hybrid-
ization. Highly expressed genes serving fundamental roles in
the cell are commonly used for this purpose but may not be
optimal under certain experimental conditions [3-5]. For
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example, the sensitivity and accuracy of northern blot analy-
sis with densitometry may be decreased using a highly
expressed housekeeper gene that can saturate the autoradio-
graphic signal [6]. To resolve this problem and compensate
for limitations in dynamic range, control genes may be chosen
to have a level of gene expression similar to the gene(s) of
interest (that is, the test genes).
Microarrays are more practical for genome-wide expression
analysis than northern blots [7]. With cDNA microarrays, a
common reference sample is usually used to compare the
expression of each gene across many experimental sample(s)
[8,9]. Because each gene in the experimental sample is
directly compared to the same gene in the common reference,
housekeeper genes are not necessary for normalization.
Microarrays are commonly applied to finding genes with dif-
ferential expression across experimental conditions, however
the data may also be used to identify stably expressed genes
that can serve as important controls for northern blot analy-
sis, ribonuclease protection assays and quantitative reverse
transcription PCR (RT-PCR). In turn, these other quantita-
tive methods are often used to verify differentially expressed
genes identified by microarray [10-12].
Housekeeper genes are often adopted from the literature and
used across a variety of experimental conditions, some of
which may induce differences in their expression. If unrecog-
nized, unexpected changes in housekeeper expression could
result in erroneous conclusions about real biological effects
such as responses to drugs. In addition, this type of change
would be difficult to detect because most experiments only
include a single housekeeper gene. It is difficult to determine
whether a given gene has the constitutive property of a house-
keeper when the true amount of mRNA in a sample is
unknown. As a way round this dilemma, Vandesompele et al.
postulate that gene pairs that have stable expression patterns
relative to each other are proper control genes [13]. An alter-
native method for quantitative analysis of RT-PCR data that
does not require housekeeper genes for normalization is to
use global pattern recognition (GPR). For instance, Akilesh et
al. used a GPR algorithm to search for eligible normalizing
genes within an assay plate and then used those genes as con-
trols to identify differentially expressed genes [14].
Although relative quantification using housekeeper genes is a
practical method of estimating the expression level of a test
gene, the transcript amount in the sample is a summation and
the method does not consider transcript differences on a cell-
to-cell basis. Fluorescence in situ hybridization (FISH) is clin-
ically used to determine absolute DNA copy number (for
example, HER2 amplification) in a cell, but these methods
still average the copy number after counting many cells and
the technique is expensive and laborious [15]. In situ methods
for detecting RNA transcripts have been developed but the
assays are semiquantitative and subjective [16].
In the work presented here, we applied several models to
selecting the best housekeeper genes for breast cancer and
give algorithms that can be generalized to find housekeeper
genes that are appropriate for normalizing quantitative data
within and between tissue types.
Results and discussion
One tissue type
The genes MRPL19, PSMC4, SF3A1, PUM1, ACTB and GAPD
were analyzed by real-time quantitative RT-PCR. Starting
copy numbers for the six candidate housekeeping genes were
measured across 80 primary breast tumor samples. The data
are available as Additional data file 1 with the online version
of this article. Plots of the raw and log-scaled expression lev-
els (all logarithms in this paper are natural base (e) loga-
rithms) are shown in Figure 1. The breast tumor samples are
ordered according to the mean of the log-expression levels of
all the genes. It is evident from the plot that for the raw data
the variability of within-sample measurements increases with
the mean expression, whereas the variability stays approxi-
mately the same for all the samples with the log-transforma-
tion. In addition, the log-transformation allows us to model
fold changes in expression levels in an additive way.
To select the best housekeepers for normalizing data across a
single tissue type, we tested three variations of a model
(Model 1, a-c) with real-time quantitative RT-PCR data gen-
erated from primary breast samples (see Materials and meth-
ods for details).
Model 1a
We model the expression yij of gene j in sample I by
log yij = µ + Ti + Gj + εij, where εij ~ N(0, )
where µ is the overall mean (log-) expression, Ti is the differ-
ence of the ith tissue sample from the overall average and Gj
is the difference of the jth gene from the overall average. The
key feature of this model that makes it different from a tradi-
tional ANOVA model is that it allows heteroscedastic errors to
account for different variability in the genes [17]. The varia-
bility around the gene-specific mean log-expression µ + Ti +
Gj is quantified by the error standard deviation σj. The Baye-
sian information criterion (BIC) was used to avoid overfitting
the data [18]. Model 1a had the best BIC value and was
selected from a range of competing models that included a
method with equal error variances (Model 1b in Materials and
methods) and a more complex method with correlated errors
(Model 1c in Materials and methods).
Using Model 1a, standard deviations were determined to
select the best control genes for breast cancer. Table 1 shows
that MRPL19 has the smallest variability across the breast
cancer samples and would be the best choice for a single
σ j
2http://genomebiology.com/2004/5/8/R59 Genome Biology 2004,     Volume 5, Issue 8, Article R59       Szabo et al. R59.3
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housekeeper control. Although some of the confidence inter-
vals overlap, a direct comparison between the genes selected
from the microarray (MRPL19, PSMC4, PUM1, SF3A1) to the
classical housekeepers (GAPD and ACTB) shows significant
difference (p = 0.0014).
As the biological function of many genes is still unknown, it is
difficult to predict how different experimental conditions may
affect the expression of putative housekeeper genes. Thus, a
safer approach is to use an average expression of several
genes that show small variance across conditions. On the
basis of the selected model, the estimate of the variance of the
log-average of the expression of several genes can be calcu-
lated (see Materials and methods for details). Table 2 shows
the standard deviations of the log-average of the best gene set
for each possible set size (that is, 1-6). These standard devia-
tion values are approximately equal to the coefficient of vari-
ation in the original scale. From the estimates, the four-gene
set of PSMC4, MRPL19, PUM1 and SF3A1 provides the lowest
overall variability when choosing a combination of genes.
However, this four-gene set is barely different from the three-
gene combination of MRPL19, PUM1 and PSMC4, which in
turn is far better than the best two-gene combination. For
economy, and because SF3A1 had a relatively high individual
variability compared to others in the set, our choice for the
normalizing set is the geometric mean of the expressions of
MRPL19, PUM1 and PSMC4.
These findings illustrate the importance of performing an
unbiased and genome-wide search for housekeepers rather
Relative levels of expression determined by real-time quantitative RT-PCR are shown for 6 housekeeper genes in 80 breast tumors Figure 1
Relative levels of expression determined by real-time quantitative RT-PCR are shown for 6 housekeeper genes in 80 breast tumors. The top panel displays 
the raw data and the bottom panel displays a log-scale of the data.
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than relying on traditional housekeeper genes. We used
microarray data to select genes with low variability in expres-
sion across breast tumors and cell lines. Because the quanti-
tative differences between the microarray and RT-PCR
platforms are relative, genes with low variability in expres-
sion across tumors by microarray should also show low vari-
ability in expression by RT-PCR. Although the quantitative
data from microarray tends to have an overall smaller
dynamic range compared to RT-PCR, this is primarily due to
loss of information from genes expressed at low levels. Our
microarray dataset was filtered to remove genes with signals
near background noise.
The result is very similar using Vandesompele et al.'s M value
method, with only the positions of PUM1 and PSMC4 chang-
ing in stability rank. It should be noted that the M-value
method does not order the two best genes (MRPL19  and
PSMC4). Their best gene-set selection approach would sug-
gest using the (log-scale) average of these two best genes as a
control. Such a concordance is not surprising given the close
relationship between the M value and our model using the
variability of the average of several genes (see Materials and
methods for details). A benefit of our approach is the ability
to compare the variability of individual genes to that of an
average of several genes.
Multiple tissue types
Gene(s) with minimal variation in expression across different
cell types serve as good 'universal' housekeepers. A universal
control may be a single gene or combination of genes. While
the former should display both low variability within a given
tissue type and consistent basal levels of expression across
tissue types, the latter may comprise a gene set with individ-
ually different, but complementary, basal expression levels
across tissue types.
To test our models for selecting universal housekeepers, we
used published data from Vandesompele et al. [13]. They
measured the expression level of 10 genes in neuroblastoma
cell lines (NB), cultured normal fibroblasts (FIB), normal leu-
kocytes (LEU) and cells from normal bone marrow (BM). In
addition, normal tissues from pooled organs (breast, brain,
fetal brain, heart, kidney, uterus, lung, trachea and small
intestine) were also profiled. A plot of these housekeepers
across the different tissues is shown in Figure 2. It is notable
that a gene can have stable expression within a given tissue
type but can change rank position compared to other house-
keepers across tissues. For example, GAPD has relatively high
expression in fibroblasts compared to other housekeepers but
low expression in leukocytes. Thus, GAPD may be a good
single housekeeper within certain tissue types but may not be
Table 1
Standard deviation estimates of log expression using Model 1a for selecting the single best housekeeper gene for breast cancer
Gene Estimated standard deviation 95% confidence interval
MRPL19 0.218 (0.168, 0.284)
PUM1 0.265 (0.215, 0.328)
PSMC4 0.288 (0.235, 0.352)
SF3A1 0.393 (0.327, 0.472)
ACTB 0.448 (0.376, 0.533)
GAPD 0.519 (0.439, 0.613)
Table 2
Standard deviation estimates of log expression using Model 1a for selecting the best housekeeper gene(s) for breast cancer
Set size Gene set Standard deviation
1 MRPL19 0.2182
2 PUM1, MRPL19 0.1718
3 PSMC4, MRPL19, PUM1 0.1494
4 PSMC4, MRPL19, PUM1, SP3A1 0.1490
5 PSMC4, MRPL19, SF3A1, PUM1, ACTB 0.1491
6 PSMC4, MRPL19, SF3A1, PUM1, GAPD, ACTB 0.1513http://genomebiology.com/2004/5/8/R59 Genome Biology 2004,     Volume 5, Issue 8, Article R59       Szabo et al. R59.5
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Genome Biology 2004, 5:R59
an optimal universal housekeeper unless it is used within a
complementary gene set.
Model 2
To compare the performance of h o u s e k e e p e r s  w i t h i n  a n d
between different tissues, we made a Model 2 (see Materials
and methods for further details) that models the expression
of gene j in the ith sample of tissue-type k by
log yi(k)j = µ + Ck + Ti(k) + Gj + (CG)kj + εi(k)j, where εi(k)j ~
N(0,         ))
where µ denotes the overall mean (log-) expression, Ck is the
difference of the kth tissue type from the overall average, Ti(k)
is the specific effect of the ith sample of tissue-type k, Gj is the
difference of the jth gene from the overall average and (CG)kj
is the tissue-type specific effect of gene j. Variability in calcu-
lation comes from two sources: the specific gene (σj) and the
tissue-type (ςk). The estimates of these parameters are given
in Table 3. The single gene with the overall lowest variability
within each tissue type is GAPD, followed closely by UBC
(ubiquitin C), HPRT1  (hypoxanthine phosphoribosyltrans-
ferase 1) and YWHAZ  (tyrosine 3-monooxygenase/tryp-
tophan 5-monooxygenase activation protein, zeta
polypeptide). This result correlates closely with Vandesom-
pele et al.'s approach. That is, the top five genes have exactly
the same order when we rank the genes within each tissue
type according to their M-value. Here we assign a rank of 1.5
to the unordered best pair and then average the ranks to
obtain an overall ordering of the genes.
The risk of normalizing data to a housekeeper gene with var-
iable overall expression level across different tissues can be
represented mathematically as bias error. A housekeeper that
has low bias for a particular tissue has an expression level that
is near its mean expression across tissues. In our second
model, the term (CG)kj represents this tissue-type specific
bias. The measure of variability around an intended value
when bias is present is called the mean squared error (MSE):
MSE = bias2 + variance. Thus, to find a set of genes for nor-
malization across the various tissue types we use a minimax
MSE criterion: minimizing the largest MSE of the combina-
tion. Table 4 provides a list for the best gene set of each size
along with the minimax-MSE value. Although GAPD has rel-
atively low overall variability within each tissue type, its basal
expression changes across tissue types making it a poor
choice for a single universal control. The data shows that
RPL13A (ribosomal protein L13a) is the best single universal
housekeeper, but it is clear that no single gene is optimal for
a universal housekeeper. Actually, choosing all the candidates
provides the smallest MSE, which is not surprising as the set
of all 10 genes is unbiased by definition. For routine
application it is reasonable to limit the number of control
Dataset from Vandesompele et al. [13] in log scale-showing expression levels of 10 putative housekeeper genes by sample and tissue type Figure 2
Dataset from Vandesompele et al. [13] in log-scale showing expression levels of 10 putative housekeeper genes by sample and tissue type. Tissue types 
analyzed included normal bone marrow (BM), cultured normal fibroblasts (FIB), normal leukocytes (LEU), neuroblastoma cell lines (NB), and pooled 
normal tissue from breast, brain, fetal brain, heart, kidney, uterus, lung, trachea and small intestine (POOL).
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genes, as the cost of assaying additional genes needs to
balance the extra precision obtained. With this in mind, it is
instructive to note that the three-member set of HPRT1,
RPL13A and UBC is an excellent choice because it maintains
a priority ranking even when selection is open to including
four- or five-element sets. The housekeeper genes we tested
by RT-PCR on breast tumor samples were not assayed across
other tissue types and thus could not be evaluated as univer-
sal controls. Nevertheless, it is likely that our results in breast
tissue would hold up across other tissue types as our genes
were initially selected from microarray data that included 17
different and diverse cell lines as well as primary breast
tumors [19].
Figure 3 shows the MSE of each gene broken down into the
squared-bias and variance components. The direction of each
bar shows the sign of the bias. It is apparent that the large bias
dominates the large values of MSE. The use of the (log-)
average of several genes tends to reduce the variance, due to
the effect of bias reduction where opposite biases cancel each
other out. For example, both ACTB and TBP (TATA box bind-
ing protein) have a large bias in the pooled normal samples,
but in opposing directions. The mean squared error of the
(log-) average of ACTB and TBP in these samples is only 0.35,
which is much lower than their individual MSEs above 6.
In summary, we have modeled the performance of putative
housekeepers to test their goodness-of-fit in serving as
normalization controls for relative insert quantification. A
major advantage of a model approach is that the terms are
placed within a solid statistical framework and are not ad hoc,
which allows the algorithm to be generalized to a variety of
different experimental conditions. The genes and algorithms
that we have selected for normalization should have broad
utility for diagnostics and research.
Materials and methods
Pre-selection of assayed genes from microarray 
experiments
Four candidate housekeepers (PSMC4, MRPL19, PUM1 and
SF3A1) were selected from a microarray dataset containing
40 different breast tumors, three normal breast samples and
19 cell lines representing 17 different cell lines of diverse
nature including lymphocytes, fibroblasts and epithelial cells
[8]. All experiments were done using a common reference
Table 3
Components of the standard deviation estimates of the log-expression of the data of Vandesompele et al. [13]
Standard deviation of genes (σj)
GAPD UBC HPRT1 YWHAZ SDHA RPL13A TBP HMBS ACTB B2M
0.211 0.226 0.227 0.232 0.255 0.339 0.339 0.431 0.460 0.562
Tissue-type specific multipliers (ςk)
Bone marrow Cultured normal fibroblasts Neuroblastoma cell lines Normal leukocytes Pooled*
1.000 1.204 1.582 1.879 2.014
*Pooled normal tissue from breast, brain, fetal brain, heart, kidney, uterus, lung, trachea and small intestine.
Table 4
Minimax MSE optimal gene sets for each set size
Maximum number of members Gene set Maximal MSE
1 RPL13A 0.544
2 HPRT1, UBC 0.328
3 HPRT1, RPL13A, UBC 0.136
4 HPRT1, RPL13A, UBC 0.136
5 HPRT1, RPL13A, UBC 0.136
6 ACTB, HPRT1, SDHA, TBP, UBC, YWHAZ 0.131
7 ACTB, HPRT1, RPL13A, SDHA, TBP, UBC, YWHAZ 0.064
8 ACTB, HPRT1, RPL13A, SDHA, TBP, UBC, YWHAZ 0.064
9 ACTB, HPRT1, RPL13A, SDHA, TBP, UBC, YWHAZ 0.064
10 ACTB, B2M, GAPD, HMBS, HPRT1, RPL13A, SDHA, TBP, UBC, YWHAZ 0.049http://genomebiology.com/2004/5/8/R59 Genome Biology 2004,     Volume 5, Issue 8, Article R59       Szabo et al. R59.7
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strategy in which all experimental samples are compared to
the same reference comprised of a pool of RNAs isolated from
11 diverse human cell lines [19].
To select housekeepers, we first 'filtered' the microarray data
to select genes with Cy3 and Cy5 signal intensities greater
than 500 units across at least 75% of the experiments. This
requirement ensures that the gene is well expressed not only
in the experimental samples, but also in the common refer-
ence sample. Next, we used the SAS/STAT Analysis Package
Version 8 (SAS Institute Inc., Cary, NC) to identify a set of
genes that showed a small range of expression across sample
types and the least variance of the array-mean normalized
log-ratios. For real-time RT-PCR, we selected four of the top
six genes - PUM1, PSMC4, MRPL19 and SF3A. The two other
low-variability genes identified in the data were IER3 (imme-
diate early response 3) and SRY ((sex determining region Y)-
box 2). We did not select these genes because of their poten-
tial for being differentially regulated under other conditions.
However, we did include GAPD  and  ACTB, which are
commonly used reference genes [20], in the set of candidate
genes for comparison to the microarray selection.
Samples and cDNA preparation
Breast samples were acquired under informed consent and
received at the Huntsman Cancer Institute (Salt Lake City,
UT) for gene expression analysis (University of Utah, IRB
#8533). All specimens were expediently processed in pathol-
ogy upon arrival from surgery. Samples were grossly
dissected, procured by flash freezing in liquid nitrogen, and
stored at -80°C until RNA extraction. Approximately 50-100
mg cancer tissue was homogenized from each sample, and
total RNA was prepared using the RNeasy midi kit (Qiagen).
The integrity of RNA was determined using the RNA 6000
Nano LabChip kit (Agilent Technologies) and an Agilent 2100
Bioanalyzer. Two microliters of total RNA (50 ng/µl) were
heated to 70°C and 1 µl was loaded on the column. Degrada-
tion was evaluated using the signal of the 18S and 28S ribos-
omal peaks [21].
First-strand cDNA was synthesized from 1 µg total RNA using
oligo(dT) primers and Superscript III reverse transcriptase
following manufacturer's instructions (Superscript III First-
Strand Synthesis System, Invitrogen Life Technologies).
Briefly, the reaction was held at 48°C for 50 min, followed by
Mean squared error (MSE) of each gene by tissue-type Figure 3
Mean squared error (MSE) of each gene by tissue-type. The sign is determined by the direction of the bias. The MSE is broken down into the contributing 
components of the squared bias (Bias2) and the variance (Sigma2). Dataset from Vandesompele et al. [13]. Tissue types analyzed included normal bone 
marrow (BM), cultured normal fibroblasts (FIB), normal leukocytes (LEU), neuroblastoma cell lines (NB), and pooled normal tissue from breast, brain, fetal 
brain, heart, kidney, uterus, lung, trachea and small intestine (POOL).
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a 15 min step at 70°C. The cDNA was washed on QIAquick
PCR purification column (Qiagen) and eluted in 2 × 50 µl of
elution buffer. The cDNA was then diluted in TE' (10 mM Tris,
0.1 mM EDTA, pH 8.0), aliquoted and stored at -80°C for fur-
ther use.
Real-time quantitative PCR
All PCR reactions were performed on the LightCycler. Each
20 µl reaction included 1 × PCR buffer with 3 mM MgCl2
(Idaho Technology), 0.2 mM each of dATP, dCTP, and dGTP
(Roche), 0.1 mM dTTP (Roche), 0.3 mM dUTP (Roche), 1 U
of Platinum taq (Invitrogen Life Technologies), 1/40000
SYBR Green I (Molecular Probes), approximately 5 ng cDNA,
and 0.4 µM of each primer. The primers used for the RNA
control genes are shown in Table 5.
PCR was done using the following protocol: initial denatura-
tion 95°C for 1 min 30 sec, then 50 cycles at 94°C for 1 sec for
denaturation, 60°C for 5 sec (20°C/sec transition) for anneal-
ing, 72°C for 8 sec (2°C/sec transition) for extension. Fluores-
cence emission of SYBR Green I (channel 1, 530 nm) was
acquired each cycle after the extension step. A melting step
was performed after PCR to determine product purity. For
melting curve analysis, the reactions were rapidly (20°C/sec)
cooled from 95°C to 60°C and then slowly heated (0.1°C/sec)
back to 95°C while continuously monitoring fluorescence.
Table 5
Primers for housekeeper genes
Length (bases) GC(%) *Tm (°C)
PSMC4 (UniGene reference Hs.211594 - Gene ID: 5704)
GGCATGGACATCCAGAAG 18 55.6 60
CCACGACCCGGATGAAT 17 58.8 61
Amplified fragment 190 61 90
MRPL19 (UniGene reference Hs.44024 - Gene ID: 9801)
GGGATTTGCATTCAGAGATCAG 22 45 62
GGAAGGGCATCTCGTAAG 18 56 61
Amplified fragment 182 44 83
PUM1 (UniGene reference Hs.153834 - Gene ID:9698)
TGAGGTGTGCACCATGAAC 19 53 61
CAGAATGTGCTTGCCATAGG 20 50 61
Amplified fragment 187 53 87
SF3A1 (UniGene reference Hs.406277 -Gene ID:10291)
GGAGGATTCTGCACCTTCTAA 21 47 61
GCGGTAGTAGGCATGGTAA 19 52 60
Amplified fragment 196 48 85
ACTB (UniGene reference Hs.426930 - Gene ID:60)
TTCCTGGGCATGGAGTC 17 59 60
CAGGTCTTTGCGGATGTC 18 55 60
Amplified fragment 84 55 84
†GAPD (UniGene reference Hs.169476 - Gene ID:2597)
AACAGCCTCAAGATCATCAGC 21 48 63
GGATGATGTTCTGGAGAGCC 20 55 62
Amplified fragment 198 56 89
*Primers Tm determined using Tm Utility with algorithms adapted from Santa Lucia [23]. The Tm for the amplified fragment is the empirical Tm. 
†Primers for GAPD [20].http://genomebiology.com/2004/5/8/R59 Genome Biology 2004,     Volume 5, Issue 8, Article R59       Szabo et al. R59.9
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Relative quantification
Copy number was determined using the crossing point (Cp)
value, which is automatically calculated using the LightCycler
3.5 software (Roche Molecular Biochemicals). The Cp value is
reported as a fractional cycle number that is determined from
the second derivative maximum (point of maximum acceler-
ation) on the PCR amplification curve (fluorescence versus
cycle number) [22]. A relative s t a r t i n g  c o p y  n u m b e r  w a s
determined for each housekeeper using a calibration curve
done with the same batch of master mix. Efficiency (E) of PCR
was calculated from a plot of Cp versus log ng cDNA [22].
E = 10-1/slope
Modeling expression data
As the effects of interest are fold changes, we modeled the log-
transformed expression Model 1a.
log yij = µ + Ti + Gj + εij,
where   independent
where µ denotes the overall mean (log) expression, Ti is the
difference of the ith tissue sample from the overall average
and Gj is the difference of the jth gene from the overall aver-
age. The key feature of this model that makes it different from
a traditional ANOVA model is that it allows heteroscedastic
errors: the variability of the genes is different.
We fitted the model using the gls routine of the nlme library
for R, however other commonly available software such as
PROC MIXED from SAS could have been used.
Based on the model, the variability of the logarithm of the
geometric mean
of a gene-set S was estimated as
Vandesompele  et al.'s  M-value is the average of relative
standard deviations of the log-expression levels. Under
Model 1, the M-value of the gene is closely related to its vari-
ance (under Models 2 and 3 below, the similar relationships
can be derived):
We tested the assumption of unequal variances by fitting
Model 1b that forces all the genes to have the same variability
(this is the classical ANOVA model).
log yij = µ + Ti + Gj + εij,
where   independent
Model 1c with a correlated error structure can be used to
assess the assumption of (conditional) independence of the
genes given the sample mean. If warranted, a more compli-
cated correlation structure can be imposed.
log yij = µ + Ti + Gj + εij,
where 
For the multiple tissue-type set-up the notation and the
model need to be extended. We will denote the expression
level of gene j of in the ith sample of type k by yi(k)j, i = 1,...nk,
j = 1,...,g and k = 1,...,m. The best-fitting model for the data,
which we call Model 2, had the form
log yi(k)j = µ + Ck + Ti(k) + Gj + (CG)kj + εi(k)j,
where
Thus the errors are independent and their variability is
decomposed into a gene-specific and tissue-type specific mul-
tiplicative components. The last restriction ensures the
uniqueness of the solution. Simpler models that we consid-
ered used uniform error variance, equal error variance for tis-
sue types, and equal error variance for genes. We also
considered more complex models that used exchangeable
correlation structure for the errors and unstructured error
variance (each gene-tissue-type combination has a variance
parameter). The BIC was used as a basis for model selection.
Additional data files
Additional data available with this paper online is an Excel
file with the relative copy numbers of six genes in the 80
breast cancer samples used in this study (Additional data file
1).
Additional data file 1 An Excel file with the relative copy numbers of six genes in the 80  breast cancer samples used in this study An Excel file with the relative copy numbers of six genes in the 80  breast cancer samples used in this study Click here for additional data file
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